Development of a Novel, Oral Orexin Receptor 2 Agonist, ORX750 for Treatment of Patients with Narcolepsy (type 1 and 2) and Idiopathic Hypersomnia

ORX750 - Centessa

G. Plazzi1; Y. Dauvilliers2; D. Plante3; E. Mignot4; T. Roth5; M. Sterkel6; E.B. Leary6; D. Hartman6; M.A. Accardi6; S. Saha6; S. Kanes6

Sep 3, 2025